|
|
Objectives and Subobjectives
Goal: Prevent disease,
disability, and death from infectious diseases, including vaccine-preventable
diseases.
As a result of the Healthy People 2010 Midcourse
Review, changes were made to the Healthy People 2010 objectives and subobjectives.
These changes are specific to the following
situations:
-
Changes in
the wording of an objective to more accurately describe what is being
measured.
-
Changes to
reflect a different data source or new science.
-
Changes
resulting from the establishment of a baseline and a target (that is, when a
formerly developmental objective or subobjective became measurable).
-
Deletion of
an objective or subobjective that lacked a data source.
-
Correction of errors and omissions in Healthy People 2010.
Revised baselines and targets for measurable objectives and
subobjectives do not fall into any of the above categories and, thus, are not
considered a midcourse review change.1
When changes were made to an objective, three
sections are displayed:
-
In the
Original Objective section, the objective as published in Healthy People 2010 in
2000 is shown.
-
In the
Objective With Revisions section, strikethrough indicates text deleted, and
underlining is used to show new text.
-
In the Revised Objective section, the objective appears as revised
as a result of the midcourse review.
Details of the objectives and subobjectives in this
focus area, including any changes made at the midcourse, appear on the
following pages.
1See Technical Appendix for more information on
baseline and target revisions.
Diseases
Preventable Through Universal Vaccination
NO
CHANGE IN OBJECTIVE
(Data
updated and footnoted)
|
14-1. |
Reduce
or eliminate indigenous cases of vaccine-preventable diseases.
Target
and baseline:
Objective |
Reduction in
Vaccine-Preventable Diseases |
1998
Baseline
(unless noted)
Number of Cases |
2010
Target
Number of Cases |
14-1a.
| Congenital rubella syndrome
(children under age 1 year) |
7 |
0 |
14-1b. |
Diphtheria (persons under
age 35 years) |
1 |
0 |
14-1c. |
Haemophilus influenzae type b* (children under age 5 years) |
163 |
0 |
14-1d. |
Hepatitis B (persons aged 2
to 18 years) |
|
|
14-1e. |
Measles (persons of all
ages) |
74 |
0 |
14-1f. |
Mumps (persons of all ages) |
666 |
0 |
14-1g. |
Pertussis (children under
age 7 years) |
3,417 |
2,000 |
14-1h. |
Polio (wild-type virus)
(persons of all ages) |
0 |
0 |
14-1i. |
Rubella (persons of all
ages) |
364 |
0 |
14-1j. |
Tetanus (persons under age
35 years) |
14 |
0 |
14-1k. |
Varicella (chicken pox)
(persons aged 17 years and under) |
|
|
* Includes cases with type b and unknown serotype.
† Estimated
hepatitis B cases for 1997.
‡ Data based on
average from 1999 for persons of all ages.
Target
setting method:
Total
elimination for congenital rubella syndrome, diphtheria, Haemophilus influenzae
type b, measles, mumps, polio, rubella, and tetanus; 41 percent improvement
for pertussis; 99 percent improvement for hepatitis B and varicella.
Data
sources:
National
Notifiable Disease Surveillance System (NNDSS), CDC, EPO; National Congenital
Rubella Syndrome Registry (NCRSR), CDC, NIP—congenital rubella syndrome;
Active Bacterial Core Surveillance (ABCs), Emerging Infections Programs, CDC,
NCID—Haemophilus
influenzae type b; National Health Interview Survey (NHIS), CDC,
NCHS—varicella.
1 Baseline revised from 945 after
November 2000 publication.
2 Target revised from 9 because of
baseline revision after November 2000 publication.
3 Baseline and baseline year revised from 4 million and 1990–94
after November 2000 publication.
4 Target revised from 400,000 because of
baseline revision after November 2000 publication.
|
NO
CHANGE IN OBJECTIVE
|
14-2. |
Reduce
chronic hepatitis B virus infections in infants and young children (perinatal
infections).
Target:
400 infections.
Baseline:
1,682 chronic hepatitis B virus infections
in infants and children aged 2 years and under were reported in 1995.
Target
setting method:
76 percent
improvement.
Data
sources:
Perinatal
Hepatitis B Prevention Program, CDC, NCID; National Vital Statistics System
(NVSS), CDC, NCHS; State Perinatal Hepatitis B Prevention Programs; State
Vital Statistics Systems.
|
NO
CHANGE IN OBJECTIVE
(Data updated and footnoted)
|
14-3. |
Reduce
hepatitis B.
Target
and baseline:
Objective |
Reduction in Hepatitis B |
1997
Baseline
Rate per 100,000
Population |
2010
Target
Rate per 100,000
Population |
|
Adults |
|
|
14-3a. |
19 to 24 years |
|
|
14-3b. |
25 to 39 years |
|
|
14-3c. |
40 years and older |
|
|
|
High-risk groups |
Number of Cases |
Number of Cases |
14-3d. |
Injection drug users |
|
|
14-3e. |
Heterosexually active
persons |
|
|
14-3f. |
Men who have sex with men |
|
|
14-3g. |
Occupationally exposed
workers |
|
|
Target
setting method: For 14-3a,
14-3b, and 14-3c, better than the best; for 14-3d, 14-3f, and 14-3g, 75
percent improvement; for 14-3e, 92 percent improvement.
Data
sources: National
Notifiable Disease Surveillance System (NNDSS), CDC, EPO; Sentinel Counties
Study of Viral Hepatitis, CDC, NCID.
1 Baseline revised from 24.0 after November 2000 publication.
2 Target revised from 2.4 because of baseline revision after November 2000
publication.
3 Baseline revised from 20.2 after November 2000 publication.
4 Target revised from 5.1 because of baseline revision after November 2000
publication.
5 Baseline revised from 15.0 after November 2000 publication.
6 Target revised from 3.8 because of baseline revision after November 2000
publication.
7 Baseline revised from 7,232 after November 2000 publication.
8 Target revised from 1,808 because of baseline revision after November 2000
publication.
9 Baseline revised from 15,225 after November 2000 publication.
10 Target revised from 1,240 because of baseline
revision after November 2000 publication.
11 Baseline
revised from 7,232 after November 2000 publication.
12 Target revised from 1,808 because of
baseline revision after November 2000 publication.
13 Baseline
revised from 249 after November 2000 publication.
14 Target revised from 62 because of baseline
revision after November 2000 publication.
|
NO
CHANGE IN OBJECTIVE
|
14-4. |
Reduce
bacterial meningitis in young children.
Target:
8.6 new cases per 100,000 children aged 1
through 23 months.
Baseline:
13.0 new cases of bacterial meningitis per
100,000 children aged 1 through 23 months were reported in 1998.
Target
setting method:
34 percent
improvement.
(Better than the best
will be used when data are available.)
Data
source:
Active Bacterial
Core Surveillance (ABCs), Emerging Infections Program Network, CDC,
NCID.
|
NO
CHANGE IN OBJECTIVE
(Data updated and footnoted)
|
14-5. |
Reduce
invasive pneumococcal infections.
Target
and baseline:
Objective |
Reduction in Invasive
Pneumococcal Infections |
1997
Baseline
Rate per 100,000 |
2010
Target
Rate per 100,000 |
|
New invasive pneumococcal infections |
|
|
14-5a. |
Children under age 5 years |
|
|
14-5b. |
Adults aged 65 years and
older |
62 |
42 |
|
Invasive penicillin-resistant pneumococcal infections |
|
|
14-5c. |
Children under age 5 years |
16 |
6 |
14-5d. |
Adults aged 65 years and
older |
|
|
Target
setting method:
Better
than the best.
Data
sources:
Active Bacterial
Core Surveillance (ABCs), Emerging Infections Program Network, CDC, NCID;
Arctic Investigations Program (for data on pneumococcal disease rates among
Alaska Natives), CDC.
1 Baseline revised from 76 after November
2000 publication.
2 Target revised from 46 because of
baseline revision after November 2000 publication.
3 Baseline revised from 9 after November
2000 publication.
4 Target revised from 7 because of
baseline revision after November 2000 publication.
|
Diseases
Preventable Through Targeted Vaccination
NO
CHANGE IN OBJECTIVE
(Data updated and footnoted)
|
14-6. |
Reduce
hepatitis A.
Target:
4.31 new cases per 100,000
population.
Baseline:
11.22 new cases of hepatitis A
per 100,000 population were reported in 1997.
Target
setting method:
Better
than the best.
Data
source:
National
Notifiable Disease Surveillance System (NNDSS), CDC, EPO.
1 Target revised from 4.5 because of
baseline revision after November 2000 publication.
2 Baseline revised from 11.3 after
November 2000 publication.
|
NO
CHANGE IN OBJECTIVE
|
14-7. |
Reduce
meningococcal disease.
Target:
1.0 new cases per 100,000 population.
Baseline:
1.3 new cases of meningococcal disease per
100,000 population were reported in 1997.
Target
setting method:
Better
than the best.
Data
sources:
Active Bacterial
Core Surveillance (ABCs), Emerging Infections Program Network, CDC, NCID;
National Notifiable Diseases Surveillance System (NNDSS), CDC, EPO.
|
Infectious
Diseases and Emerging Antimicrobial Resistance
NO
CHANGE IN OBJECTIVE
|
14-8. |
Reduce
Lyme disease.
Target:
9.7 new cases per 100,000 population in
endemic States.
Baseline:
17.4 new cases of Lyme disease per 100,000
population were reported in 1992–96.
Target
setting method:
44 percent
improvement.
(Better than the best
will be used when data are available.)
Potential
data source:
National
Notifiable Disease Surveillance System (NNDSS), CDC, EPO.
|
NO
CHANGE IN OBJECTIVE
(Data updated and footnoted)
|
14-9. |
Reduce
hepatitis C.
Target:
1.0 new cases per 100,000 population.
Baseline:
2.51 new cases of hepatitis C
per 100,000 population in selected counties were reported in 1997.1, 2
Target
setting method:
Better
than the best.
Data
source:
Sentinel Counties
Study of Viral Hepatitis, CDC, NCID.
1 Baseline and baseline year revised from
2.4 and 1996 after November 2000 publication.
2 Baseline data are from selected
counties, all other data are based on national reporting.
|
ORIGINAL
OBJECTIVE
|
14-10. |
(Developmental)
Increase the proportion of persons with chronic hepatitis C infection
identified by State and local health departments.
Potential
data sources:
State health
department databases of persons with HCV infection; National Health and
Nutrition Examination Survey (NHANES), CDC, NCHS.
|
OBJECTIVE
WITH REVISIONS
|
14-10. |
(Developmental)
Increase the proportion of persons withnumber of States and the
District of Columbia identifying persons with chronic hepatitis C
infection identified by State and local health departments.
Potential
data sources:
National
Notifiable Disease Surveillance System (NNDSS), State health
department databases of persons with HCV infection; National Health and
Nutrition Examination Survey (NHANES), CDC, EOPNCHS.
|
REVISED
OBJECTIVE
|
14-10. |
(Developmental)
Increase the number of States and the District of Columbia identifying
persons with chronic hepatitis C infection.
Potential
data source:
National
Notifiable Disease Surveillance System (NNDSS), CDC, EPO.
|
NO
CHANGE IN OBJECTIVE
|
14-11. |
Reduce
tuberculosis.
Target:
1.0 new cases per 100,000 population.
Baseline:
6.8 new cases of tuberculosis per 100,000
population were reported in 1998.
Target
setting method:
Better
than the best.
Data
source:
National TB
Surveillance System, CDC, NCHSTP.
|
NO
CHANGE IN OBJECTIVE
|
14-12. |
Increase
the proportion of all tuberculosis patients who complete curative therapy
within 12 months.
Target:
90 percent of patients.
Baseline:
74 percent of those tuberculosis patients
reported in 1996 and started on therapy completed therapy within 12
months.
Target
setting method:
Better
than the best.
Data
source:
National TB
Surveillance System, CDC, NCHSTP.
|
ORIGINAL
OBJECTIVE
|
14-13. |
Increase
the proportion of contacts and other high-risk persons with latent
tuberculosis infection who complete a course of treatment.
Target:
85 percent.
Baseline:
62 percent of tuberculosis contacts and
other high-risk persons who started on treatment for latent TB infection in
1997 completed treatment.
Target
setting method:
27 percent
improvement.
(Better than the best
will be used when data are available.)
Data
source:
Aggregate Reports
for TB Reports Evaluation, CDC, NCHSTP.
|
OBJECTIVE
WITH REVISIONS
|
14-13. |
Increase
the proportion of contacts and other high-risk persons with latent
tuberculosis infection who complete a course of treatment.
Target:
8557 percent.
Baseline:
4562 percent of tuberculosis
contacts and other high-risk persons who started on treatment
with latent TB infection in 1997 2000 completed treatment.
Target
setting method:
27 percent
improvement.
(Better than the best
will be used when data are available.)
Data
source:
Aggregate Reports
for TB Reports Evaluation, CDC, NCHSTP.
|
REVISED
OBJECTIVE
|
14-13. |
Increase
the proportion of persons with latent tuberculosis infection who complete a
course of treatment.
Target:
57 percent.
Baseline: 45 percent of persons with latent TB
infection in 2000 completed treatment.
Target
setting method: 27 percent
improvement.
(Better than the best
will be used when data are available.)
Data
source: Aggregate Reports
for TB Reports Evaluation, CDC, NCHSTP.
|
NO
CHANGE IN OBJECTIVE
|
14-14. |
Reduce
the average time for a laboratory to confirm and report tuberculosis cases.
Target:
2 days for 75 percent of cases.
Baseline:
21 days were needed for a laboratory to
confirm and report 75 percent of TB cases in 1996.
Target
setting method:
90 percent
improvement.
Data
source:
Survey of State
Public Health Laboratories, CDC, NCHSTP.
|
OBJECTIVE
DELETED
|
14-15. |
(Objective deleted due to lack of
data source) (Developmental) Increase the proportion of
international travelers who receive recommended preventive services when
traveling in areas of risk for select infectious diseases:
hepatitis A, malaria, and typhoid.
|
NO
CHANGE IN OBJECTIVE
|
14-16. |
Reduce invasive
early onset group B streptococcal disease.
Target:
0.5 new cases per 1,000 live births.
Baseline:
1.0 new case of invasive early onset group
B streptococcal disease per 1,000 live births was reported in 1996.
Target
setting method:
Better
than the best.
Data
source:
Active Bacterial
Core Surveillance (ABCs), Emerging Infections Program Network, CDC,
NCID.
|
NO
CHANGE IN OBJECTIVE
|
14-17. |
Reduce
hospitalizations caused by peptic ulcer disease in the United States.
Target:
46 hospitalizations per 100,000
population.
Baseline:
71 hospitalizations per 100,000 population
occurred in 1998 (age adjusted to the year 2000 standard population).
Target
setting method:
Better
than the best.
Data
sources:
National Hospital
Discharge Survey (NHDS), CDC, NCHS.
|
NO
CHANGE IN OBJECTIVE
(Data updated and footnoted)
|
14-18. |
Reduce
the number of courses of antibiotics for ear infections for young children.
Target:
561 antibiotic courses per 100
children under age 5 years.
Baseline:
692 antibiotic courses for
otitis media per 100 children under age 5 years were prescribed during
1996–97 (2-year average).
Target
setting method:
19 percent
improvement.
Data
sources:
National
Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital
Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
1 Target revised from 88 because of
baseline revision after November 2000 publication.
2 Baseline revised from 108 after
November 2000 publication.
|
NO
CHANGE IN OBJECTIVE
|
14-19. |
Reduce
the number of courses of antibiotics prescribed for the sole diagnosis of the
common cold.
Target:
1,268 antibiotic courses per 100,000
population.
Baseline:
2,535 antibiotic courses per 100,000
population were prescribed for the sole diagnosis of the common cold,
1996–97.
Target
setting method:
50 percent
improvement.
Data
sources:
National
Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital
Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
|
ORIGINAL
OBJECTIVE
|
14-20. |
Reduce
hospital-acquired infections in intensive care unit patients.
Target
and baseline:
Objective |
Reduction in
Hospital-Acquired Infections in Intensive Care Units |
1998
Baseline
Infections per
1,000 Days’ Use |
2010
Target
Infections per
1,000 Days’ Use |
|
Intensive care unit patients |
|
|
14-20a. |
Catheter-associated urinary
tract infection |
|
|
14-20b. |
Central line-associated
bloodstream infection |
|
|
14-20c. |
Ventilator-associated
pneumonia |
11.1 |
10.0 |
|
Infants weighing 1,000 grams or less at birth in intensive
care |
|
|
14-20d. |
Central line-associated
bloodstream infection |
12.2 |
11.0 |
14-20e. |
Ventilator-associated
pneumonia |
4.9 |
4.4 |
Target
setting method:
10 percent
improvement.
(Better than the best
will be used when data are available.)
Data
source:
National
Nosocomial Infections Surveillance System (NNIS), CDC, NCID.
1 Baseline revised from 5.9 after
November 2000 publication.
2 Target revised from 5.3 because of
baseline revision after November 2000 publication.
3 Baseline revised from 5.3 after
November 2000 publication.
4 Target revised from 4.8 because of
baseline revision after November 2000 publication.
|
OBJECTIVE
WITH REVISIONS
|
14-20. |
Reduce
hospital-acquired infections in intensive care unit patients.
Target
and baseline:
Objective |
Reduction in
Hospital-Acquired Infections in Intensive Care Units |
1998
Baseline (unless noted)
Infections per
1,000 Days’ Use |
2010
Target
Infections per
1,000 Days’ Use |
|
Adult and pediatric intensive care unit patients |
|
|
14-20a. |
Catheter-associated urinary
tract infection |
|
|
14-20b. |
Central line-associated
bloodstream infection |
|
|
14-20c. |
Ventilator-associated
pneumonia |
11.1 5.9 (2002–03)
|
10.0 5.3
|
|
Infants weighing 1,000 grams or less at birth in intensive
care |
|
|
14-20d. |
Central line-associated
bloodstream infection |
12.2 |
11.0 |
14-20e. |
Ventilator-associated
pneumonia |
4.9 3.0
(2002–03)
|
4.4 2.7
|
Target
setting method: 10 percent
improvement.
(Better than the best
will be used when data are available.)
Data
source: National
Nosocomial Infections Surveillance System (NNIS), CDC, NCID.
1 Baseline revised from 5.9 after
November 2000 publication.
2 Target revised from 5.3 because of
baseline revision after November 2000 publication.
3 Baseline revised from 5.3 after
November 2000 publication.
4 Target revised from 4.8 because of
baseline revision after November 2000 publication.
|
REVISED
OBJECTIVE
|
14-20. |
Reduce
hospital-acquired infections in intensive care unit patients.
Target
and baseline:
Objective |
Reduction in
Hospital-Acquired Infections in Intensive Care Units |
1998
Baseline
(unless noted)
Infections per
1,000 Days’ Use |
2010
Target
Infections per
1,000 Days’ Use |
|
Adult and pediatric intensive care unit patients |
|
|
14-20a. |
Catheter-associated urinary
tract infection |
|
|
14-20b. |
Central line-associated
bloodstream infection |
|
|
14-20c. |
Ventilator-associated
pneumonia |
5.9 (2002–03) |
5.3 |
|
Infants weighing 1,000 grams or less at birth in intensive
care |
|
|
14-20d. |
Central line-associated
bloodstream infection |
12.2 |
11.0 |
14-20e. |
Ventilator-associated
pneumonia |
3.0 (2002–03) |
2.7 |
Target
setting method: 10 percent
improvement.
(Better than the best
will be used when data are available.)
Data
source: National
Nosocomial Infections Surveillance System (NNIS), CDC, NCID.
1 Baseline revised from 5.9 after
November 2000 publication.
2 Target revised from 5.3 because of
baseline revision after November 2000 publication.
3 Baseline revised from 5.3 after
November 2000 publication.
4 Target revised from 4.8 because of
baseline revision after November 2000 publication. |
ORIGINAL
OBJECTIVE
|
14-21. |
Reduce
antimicrobial use among intensive care unit patients.
Target:
120 daily doses per 1,000 patient
days.
Baseline:
150 daily doses of antimicrobials per
1,000 patient days were used among intensive care unit patients in 1995.
Target
setting method:
20 percent
improvement.
Data
source:
National
Nosocomial Infections Surveillance System (NNIS), CDC, NCID.
|
OBJECTIVE
WITH REVISIONS
|
14-21. |
Reduce antimicrobial
vancomycin use among intensive care unit patients.
Target:
120 85.1 doses per 1,000
patient days.
Baseline:
150106.4 doses of
vancomycin per 1,000 patient days were used among intensive care unit
patients in 19951998–2003.
Target
setting method:
20 percent
improvement.
Data
source:
National
Nosocomial Infections Surveillance System (NNIS), CDC, NCID.
|
REVISED
OBJECTIVE
|
14-21. |
Reduce
vancomycin use among intensive care unit patients.
Target:
85.1 doses per 1,000 patient days.
Baseline:
106.4 doses of vancomycin per 1,000
patient days were used among intensive care unit patients in 1998–2003.
Target
setting method: 20 percent
improvement.
Data
source: National
Nosocomial Infections Surveillance System (NNIS), CDC, NCID.
|
Vaccination
Coverage and Strategies
ORIGINAL
OBJECTIVE
|
14-22. |
Achieve
and maintain effective vaccination coverage levels for universally
recommended vaccines among young children.
Target
and baseline:
Objective |
Increase in and Maintenance
of Vaccination Coverage Levels Among Children Aged 19 to 35 Months |
1998
Baseline
Percent |
2010
Target
Percent |
14-22a. |
4 doses
diphtheria-tetanus-acellular pertussis (DTaP) vaccine |
84 |
90 |
14-22b. |
3 doses Haemophilus influenzae type b (Hib) vaccine |
93 |
90 |
14-22c. |
3 doses hepatitis B (hep B)
vaccine |
87 |
90 |
14-22d. |
1 dose measles-mumps-rubella
(MMR) vaccine |
92 |
90 |
14-22e. |
3 doses polio vaccine |
91 |
90 |
14-22f. |
1 dose varicella vaccine |
43 |
90 |
Target
setting method:
Consistent
with the Childhood Immunization Initiative.
Data
source:
National
Immunization Survey (NIS), CDC, NCHS and NIP.
|
OBJECTIVE
WITH REVISIONS
|
14-22. |
Achieve
and maintain effective vaccination coverage levels for universally
recommended vaccines among young children.
Target
and baseline:
Objective |
Increase in and Maintenance
of Vaccination Coverage Levels Among Children Aged 19 to 35 Months |
1998
Baseline (unless noted)
Percent |
2010
Target
Percent |
14-22a. |
4 doses
diphtheria-tetanus-acellular pertussis (DTaP) vaccine |
84 |
90 |
14-22b. |
3 doses Haemophilus influenzae type b (Hib) vaccine |
93 |
90 |
14-22c. |
3 doses hepatitis B (hep B)
vaccine |
87 |
90 |
14-22d. |
1 dose measles-mumps-rubella
(MMR) vaccine |
92 |
90 |
14-22e. |
3 doses polio vaccine |
91 |
90 |
14-22f. |
1 dose varicella vaccine |
43 |
90 |
14-22g. |
4 doses pneumococcal
conjugate vaccine |
20 (2002) |
90 |
14-22h. |
1 dose influenza vaccine
(aged 6 to 23 months) |
Developmental |
Developmental |
Target
setting method: Consistent
with the Childhood Immunization Initiative.
Data
source: National
Immunization Survey (NIS), CDC, NCHS and NIP.
|
REVISED
OBJECTIVE
|
14-22. |
Achieve
and maintain effective vaccination coverage levels for universally
recommended vaccines among young children.
Target
and baseline:
Objective |
Increase in and Maintenance
of Vaccination Coverage Levels Among Children Aged 19 to 35 Months |
1998
Baseline
(unless noted)
Percent |
2010
Target
Percent |
14-22a. |
4 doses
diphtheria-tetanus-acellular pertussis (DTaP) vaccine |
84 |
90 |
14-22b. |
3 doses Haemophilus influenzae type b (Hib) vaccine |
93 |
90 |
14-22c. |
3 doses hepatitis B (hep B)
vaccine |
87 |
90 |
14-22d. |
1 dose measles-mumps-rubella
(MMR) vaccine |
92 |
90 |
14-22e. |
3 doses polio vaccine |
91 |
90 |
14-22f. |
1 dose varicella vaccine |
43 |
90 |
14-22g. |
4 doses pneumococcal
conjugate vaccine |
20 (2002) |
90 |
14-22h. |
1 dose influenza vaccine
(aged 6 to 23 months) |
Developmental |
Developmental |
Target
setting method: Consistent
with the Childhood Immunization Initiative.
Data
source: National
Immunization Survey (NIS), CDC, NCHS and NIP.
|
ORIGINAL
OBJECTIVE
|
14-23. |
Maintain
vaccination coverage levels for children in licensed day care facilities and
children in kindergarten through the first grade.
Target
and baseline:
Objective |
Maintenance of Vaccination
Coverage Levels for Children |
1997–98
Baseline *
Percent |
2010
Target
Percent |
|
Children in day care |
|
|
14-23a. |
Diphtheria-tetanus-acellular
pertussis (DTaP) vaccine |
96 |
95 |
14-23b. |
Measles/mumps/rubella
vaccines |
89 |
95 |
14-23c. |
Polio vaccine |
96 |
95 |
14-23d. |
Hepatitis B vaccine |
Developmental |
Developmental |
14-23e. |
Varicella vaccine |
Developmental |
Developmental |
|
Children in K through 1st grade |
|
|
14-23f. |
Diphtheria-tetanus-acellular
pertussis (DTaP) vaccine |
97 |
95 |
14-23g. |
Measles/mumps/rubella
vaccines |
96 |
95 |
14-23h. |
Polio vaccine |
97 |
95 |
14-23i. |
Hepatitis B vaccine |
Developmental |
Developmental |
14-23j. |
Varicella vaccine |
Developmental |
Developmental |
* Weighted means.
Target
setting method:
Consistent
with year 2000 target.
(Better than
the best will be used when data are available.)
Data
source:
Immunization
Program Annual Reports, CDC, NIP.
|
OBJECTIVE
WITH REVISIONS
|
14-23. |
Maintain
vaccination coverage levels for children in licensed day care facilities and
children in kindergarten through first grade.
Target
and baseline:
Objective* |
Maintenance of Vaccination
Coverage Levels for Children |
1997–98
Baseline *† (unless noted)
Percent |
2010
Target
Percent |
|
Children in day care |
|
|
14-23a. |
Diphtheria-tetanus-acellular
pertussis (DTaP) vaccine |
96 |
95 |
14-23b. |
Measles/mumps/rubella
vaccines |
89 |
95 |
14-23c. |
Polio vaccine |
96 |
95 |
14-23d. |
Hepatitis B vaccine |
93 (2003–04) Developmental |
95 |
14-23e. |
Varicella vaccine
| 87 (2003–04) Developmental
| 95 |
|
Children in kindergarten |
|
|
14-23f. |
Diphtheria-tetanus-acellular
pertussis (DTaP) vaccine |
9795
(2002–03)
|
95 |
14-23g. |
Measles/mumps/rubella
vaccines |
96 (2002–03) |
95 |
14-23h. |
Polio vaccine |
976 (2002–03) |
95 |
14-23i. |
Hepatitis B vaccine |
96 (2002–03) Developmental |
95 |
14-23j. |
Varicella vaccine |
93 (2002–03) Developmental |
95 |
|
Children in day care |
|
|
|
Pneumococcal conjugate
vaccine |
53 (2003–04) |
95 |
|
Haemophilus influenzae type b vaccine |
94 (2003–04) |
90 |
* For data control purposes, subobjectives are not
renumbered.
† Weighted means.
Target
setting method:
Consistent
with year 2000 target.
(Better than
the best will be used when data are available.)
Data
source:
Immunization
Program Annual Reports, CDC, NIP.
|
REVISED
OBJECTIVE
|
14-23. |
Maintain
vaccination coverage levels for children in licensed day care facilities and
children in kindergarten.
Target
and baseline:
Objective* |
Maintenance of Vaccination
Coverage Levels for Children |
1997–98
Baseline † (unless noted)
Percent |
2010
Target
Percent |
|
Children in day care |
|
|
14-23a. |
Diphtheria-tetanus-acellular
pertussis (DTaP) vaccine |
96 |
95 |
14-23b. |
Measles/mumps/rubella
vaccines |
89 |
95 |
14-23c. |
Polio vaccine |
96 |
95 |
14-23d. |
Hepatitis B vaccine |
93 (2003–04) |
95 |
14-23e. |
Varicella vaccine |
87 (2003–04) |
95 |
|
Children in kindergarten |
|
|
14-23f. |
Diphtheria-tetanus-acellular
pertussis (DTaP) vaccine |
95 (2002–03) |
95 |
14-23g. |
Measles/mumps/rubella
vaccines |
96 (2002–03) |
95 |
14-23h. |
Polio vaccine |
96 (2002–03) |
95 |
14-23i. |
Hepatitis B vaccine |
96 (2002–03) |
95 |
14-23j. |
Varicella vaccine |
93 (2002–03) |
95 |
|
Children in day care |
|
|
|
Pneumococcal conjugate
vaccine |
53 (2003–04) |
95 |
|
Haemophilus influenzae type b vaccine |
94 (2003-04) |
90 |
* For data control purposes, subobjectives are not
renumbered.
† Weighted means.
Target
setting method: Consistent
with year 2000 target.
(Better than
the best will be used when data are available.)
Data
source: Immunization
Program Annual Reports, CDC, NIP.
|
NO
CHANGE IN OBJECTIVE
|
14-24. |
Increase
the proportion of young children and adolescents who receive all vaccines
that have been recommended for universal administration for at least 5 years.
Target
and baseline:
Objective |
Increase in Coverage Levels
of Universally Recommended Vaccines |
1998
Baseline
Percent |
2010
Target
Percent |
14-24a. |
Children aged 19 to 35
months who receive the recommended vaccines (4 DTaP, 3 polio, 1 MMR, 3 Hib,
3 hep B) |
73 |
80 |
14-24b. |
Adolescents aged 13 to 15
years who receive the recommended vaccines |
Developmental |
Developmental |
Target
setting method: Better
than the best.
Data
source: National
Immunization Survey (NIS), CDC, NCHS and NIP; National Health Interview
Survey (NHIS), CDC, NCHS.
|
ORIGINAL
OBJECTIVE
|
14-25. |
Increase
the proportion of providers who have measured the vaccination coverage levels
among children in their practice population within the past 2 years.
Target
and baseline:
Objective |
Increase in Providers
Measuring Vaccination Levels |
1997
Baseline
Percent |
2010
Target
Percent |
14-25a. |
Public health providers |
66 |
90 |
14-25b. |
Private providers |
6 |
90 |
Target
setting method:
36 percent
improvement for public health providers; 1,400 percent improvement for
private providers.
Data
source:
Immunization
Program Annual Reports, CDC, NIP.
|
OBJECTIVE
WITH REVISIONS
|
14-25. |
Increase
the proportion of providers who have had vaccination coverage levels among
children in their practice population have measured the
vaccination coverage levels among children in their practice
population within the past 2 years.
Target
and baseline:
Objective |
Increase in Providers
Measuring Vaccination Levels |
19979 Baseline
Percent |
2010
Target
Percent |
14-25a. |
Public health providers |
6640
|
9055
|
14-25b. |
Private providers |
611
|
9055
|
Target
setting method: 36 percent
improvement for public health providers;1,400 391 percent improvement
for private providers.
Data
source: Immunization
Program Annual Reports, CDC, NIP. |
REVISED
OBJECTIVE
|
14-25. |
Increase
the proportion of providers who have had vaccination coverage levels among
children in their practice population measured within the past 2 years.
Target
and baseline:
Objective |
Increase in Providers
Measuring Vaccination Levels |
1999
Baseline
Percent |
2010
Target
Percent |
14-25a. |
Public health providers |
40 |
55 |
14-25b. |
Private providers |
11 |
55 |
Target
setting method:
36 percent
improvement for public health providers; 391 percent improvement for private
providers.
Data
source:
Immunization
Program Annual Reports, CDC, NIP.
|
NO
CHANGE IN OBJECTIVE
(Data updated and footnoted)
|
14-26. |
Increase
the proportion of children who participate in fully operational
population-based immunization registries.
Target:
621 percent of children under
age 6 years.
Baseline:
212 percent of children under
age 6 years participated in an immunization registry in 1999.
Target
setting method:
197
percent improvement.
(Better than the
best will be used when data are available.)
Data
source:
Immunization
Program Annual Reports, CDC, NIP.
1 Target revised from 95 because of
baseline revision after November 2000 publication.
2 Baseline revised from 32 after November
2000 publication.
|
NO
CHANGE IN OBJECTIVE
|
14-27. |
Increase
routine vaccination coverage levels for adolescents.
Target
and baseline:
Objective |
Increase in Vaccination
Coverage Levels for Adolescents Aged 13 to 15 Years |
|
2010
Target
Percent |
14-27a. |
3 or more doses of hepatitis
B |
48 |
90 |
14-27b. |
2 or more doses of measles,
mumps, rubella |
89 |
90 |
14-27c. |
1 or more doses of
tetanus-diphtheria booster |
93 |
90 |
14-27d. |
1 or more doses of varicella
(excluding children who have had varicella) |
45 |
90 |
* Data are based primarily on parental recall;
provider verification has not occurred.
Target
setting method:
Consistent
with target levels established under the Childhood Immunization
Initiative.
Data
source:
National Health
Interview Survey (NHIS), CDC, NCHS.
|
NO
CHANGE IN OBJECTIVE
(Data updated and footnoted)
|
14-28. |
Increase
hepatitis B vaccine coverage among high-risk groups.
Target
and baseline:
Objective |
Increase in Hepatitis B
Vaccine Coverage in High-Risk Groups |
1995
Baseline
Percent |
2010
Target
Percent |
14-28a. |
Long-term hemodialysis
patients |
35 |
90 |
14-28b. |
Men who have sex with men |
9 |
60 |
14-28c. |
Occupationally exposed
workers |
|
|
Target
setting method:
157
percent improvement for long-term hemodialysis patients; 567 percent
improvement for men who have sex with men; 38 percent improvement for
occupationally exposed workers.
Data
sources:
Young Men’s
Survey, CDC, NCHSTP; Annual Survey of Chronic Hemodialysis Centers, CDC,
NCID, and CMS; periodic vaccine coverage surveys, CDC, NCID.
1 Baseline revised from 71 after November
2000 publication.
2 Target revised from 98 because of
baseline revision after November 2000 publication.
|
ORIGINAL
OBJECTIVE
|
14-29. |
Increase
the proportion of adults who are vaccinated annually against influenza and
ever vaccinated against pneumococcal disease.
Target
and baseline:
Objective |
Increase in Adults
Vaccinated |
1998
Baseline * (unless noted)
Percent |
2010
Target
Percent |
|
Noninstitutionalized adults aged 65 years and older |
|
|
14-29a. |
Influenza vaccine |
64 |
90 |
14-29b. |
Pneumococcal vaccine |
46 |
90 |
|
Noninstitutionalized high-risk adults aged 18 to 64 years |
|
|
14-29c. |
Influenza vaccine |
26 |
60 |
14-29d. |
Pneumococcal vaccine |
13 |
60 |
|
Institutionalized adults (persons in long-term or nursing
homes)† |
|
|
14-29e. |
Influenza vaccine |
59 (1997) |
90 |
14-29f. |
Pneumococcal vaccine |
25 (1997) |
90 |
* Age adjusted to the year 2000 standard population.
† National Nursing Home Survey estimates
include a significant number of residents who have an unknown vaccination
status.
See Tracking Healthy People 2010
for further discussion of the data issues.
Target
setting method:
Better
than the best.
Data
sources:
National Health
Interview Survey (NHIS), CDC, NCHS—noninstitutionalized populations; National
Nursing Home Survey (NNHS), CDC, NCHS—institutionalized populations.
|
OBJECTIVE
WITH REVISIONS
|
14-29. |
Increase
the proportion of adults who are vaccinated annually against influenza and
ever vaccinated against pneumococcal disease.
Target
and baseline:
Objective |
Increase in Adults
Vaccinated |
1998
Baseline * (unless noted)
Percent |
2010
Target
Percent |
|
Noninstitutionalized adults aged 65 years and older |
|
|
14-29a. |
Influenza vaccine |
64 |
90 |
14-29b. |
Pneumococcal vaccine |
46 |
90 |
|
Noninstitutionalized high-risk adults aged 18 to 64 years |
|
|
14-29c. |
Influenza vaccine |
26 |
60 |
14-29d. |
Pneumococcal vaccine |
13 |
60 |
|
Institutionalized adults (persons aged 18 years and older in long-term or nursing homes)† |
|
|
14-29e. |
Influenza vaccine |
59 (1997) |
90 |
14-29f. |
Pneumococcal vaccine |
25 (1997) |
90 |
|
Noninstitutionalized adults aged 18 to
64 years |
|
|
14-29g. |
Influenza vaccine for
health care workers |
37 (2000) |
60 |
* Age adjusted to the year 2000 standard population.
† National Nursing Home Survey estimates
include a significant number of residents who have an unknown vaccination
status.
See Tracking Healthy People 2010 for further discussion of the data issues.
Target
setting method: Better
than the best.
Data
sources: National Health
Interview Survey (NHIS), CDC, NCHS—noninstitutionalized populations; National
Nursing Home Survey (NNHS), CDC, NCHS—institutionalized populations.
|
REVISED
OBJECTIVE
|
14-29. |
Increase
the proportion of adults who are vaccinated annually against influenza and
ever vaccinated against pneumococcal disease.
Target
and baseline:
Objective |
Increase in Adults
Vaccinated |
1998
Baseline * (unless noted)
Percent |
2010
Target
Percent |
|
Noninstitutionalized adults aged 65 years and older |
|
|
14-29a. |
Influenza vaccine |
64 |
90 |
14-29b. |
Pneumococcal vaccine |
46 |
90 |
|
Noninstitutionalized high-risk adults aged 18 to 64 years |
|
|
14-29c. |
Influenza vaccine |
26 |
60 |
14-29d. |
Pneumococcal vaccine |
13 |
60 |
|
Institutionalized adults (persons aged 18 years and older in
long-term or nursing homes)† |
|
|
14-29e. |
Influenza vaccine |
59 (1997) |
90 |
14-29f. |
Pneumococcal vaccine |
25 (1997) |
90 |
|
Noninstitutionalized adults aged 18 to 64 years |
|
|
14-29g. |
Influenza vaccine for health
care workers |
37 (2000) |
60 |
* Age adjusted to the year 2000 standard population.
† National Nursing Home Survey estimates
include a significant number of residents who have an unknown vaccination
status.
See Tracking Healthy People 2010 for further discussion of the data issues.
Target
setting method: Better
than the best.
Data sources: National Health Interview Survey (NHIS),
CDC, NCHS—noninstitutionalized populations; National Nursing Home Survey
(NNHS), CDC, NCHS—institutionalized populations.
|
Vaccine Safety
NO
CHANGE IN OBJECTIVE
|
14-30.
14-30a.
14-30b. |
Reduce
vaccine-associated adverse events.
Eliminate vaccine-associated paralytic
polio (VAPP).
Target: Zero cases.
Baseline: 5 VAPP cases occurred in 1997.
Target
setting method: Total
elimination.
Data
source: National
Notifiable Disease Surveillance System (NNDSS), CDC, EPO.
Reduce febrile seizures following
pertussis vaccines.
Target: 75 febrile seizures.
Baseline: 152 febrile seizures followed pertussis
vaccines in 1998.
Target
setting method: 50
percent improvement.
Data
sources: Vaccine
Adverse Event Reporting System (VAERS); Vaccine Safety Datalink (VSD), CDC,
NIP.
|
ORIGINAL
OBJECTIVE
|
14-31. |
Increase
the number of persons under active surveillance for vaccine safety via large
linked databases.
Target:
13 million persons.
Baseline:
6 million persons were under active
surveillance for vaccine safety via large linked databases in 1999.
Target
setting method:
117
percent improvement.
Data
source:
Vaccine Safety
Datalink, CDC, NIP.
|
OBJECTIVE
WITH REVISIONS
|
14-31. |
Increase
the number of persons under active surveillance for vaccine safety via
large linked databases scientific knowledge on vaccines and adverse
events.
Target
and baseline:
Objective |
Increase in the
Scientific Knowledge on Vaccines
and Adverse Events |
1999
Baseline (unless noted)
Number of Persons
(in Millions)
|
2010
Target
Number of Persons
(in Millions) |
14-31a. |
Persons under active
surveillance for vaccine safety
via large linked databases |
6 |
13 |
|
|
Percent |
Percent |
14-31b. |
Proportion of total
Vaccine Adverse Event Reporting
System (VAERS) reports submitted electronically |
12 (2003) |
30 |
Target
setting method:
For
14-31a, 117 percent improvement; for 14-31b, expert judgment
and knowledge of programs currently in place.
Data
sources:
Vaccine Safety
Datalink, CDC, NIP; Vaccine Adverse Events Reporting System
(VAERS), CDC, NIP.
|
REVISED
OBJECTIVE
|
14-31. |
Increase
the scientific knowledge on vaccines and adverse events.
Target
and baseline:
Objective |
Increase in the Scientific
Knowledge on Vaccines and Adverse Events |
1999
Baseline
(unless noted)
Number of Persons
(in Millions) |
2010
Target
Number of Persons
(in Millions) |
14-31a. |
Persons under active
surveillance for vaccine safety via large linked databases |
6 |
13 |
|
|
Percent |
Percent |
14-31b. |
Proportion of total Vaccine
Adverse Event Reporting System (VAERS) reports submitted electronically |
12 (2003) |
30 |
Target
setting method:
For
14-31a, 117 percent improvement; for 14-31b, expert judgment and knowledge of
programs currently in place.
Data
sources:
Vaccine Safety
Datalink, CDC, NIP; Vaccine Adverse Event Reporting System (VAERS), CDC,
NIP.
|
<< Previous—Disparities Table: Income, Location, and Disability
| Table of Contents | Next—References
>>
[ Top ]
|